Main Library

Building A Value-Based Care Model in Life Sciences

March 28, 2018Evan ShirleyNo CommentsClarkston ConsultingPartnerships, Collaboration, Network Development

Value-based care models are the future of pharmaceuticals but several obstacles exist slowing the transition from volume selling to value selling. More and more, companies in this space are realizing that a traditional “pharma-first” approach is no longer enough to be successful in the future. Instead, they must evolve to adopt a more patient-centric approach designed around building trust with partners.

According to a 2015 study published in JAMA, only 148 risk-sharing agreements were established by life sciences companies between 1990 and 2013, and only 12% of those were in the US. Since 2013, the growth rate of risk-sharing, value-based, and outcomes-based models has begun to slowly accelerate.

In working on several elements of new value-based care models with companies at various points in their evolution, we recognize that this journey is very difficult. But it is a journey that is required to realize the promise of patient-centric care and to truly begin to rebuild trust in healthcare. Below are three insights to integrate into your planning and execution, designed to be usable by any company regardless of where you are in the evolution of your value-based care model.

Full Article

: Life Sciences, Pharmaceuticals, value based

Related Posts

To Sustain The Value Movement, Make Next Generation ACOs A Permanent Option

April 9, 2021Garrett Schmitt

Bipartisan House bill aims to boost value-based purchasing drug agreements in Medicaid

April 7, 2022aco

HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett Schmitt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Trends in Market Share Among Hospitals Participating in ACOs and Nonparticipants
  • CMMI Model Reports and Findings
  • One Big Beautiful Bill Act — What physicians need to know
  • From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
  • Transparency in Coverage Final Rule
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us